Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
FEBS Letters|October 22, 2002
PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1Koji Nakagawa, Hideyoshi YokosawaBiological & Pharmaceutical Bulletin|May 3, 2008
Small ubiquitin-related modifier is secreted and shows cytokine-like activityHidetaka Hosono, Hideyoshi YokosawaBiological & Pharmaceutical Bulletin|April 2, 2004
Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathwaysMegumi Yamakami, Hideyoshi YokosawaPlanta Medica|February 27, 2010
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapySachiko Tsukamoto, Hideyoshi YokosawaCurrent Medicinal Chemistry|April 14, 2006
Natural products inhibiting the ubiquitin-proteasome proteolytic pathway, a target for drug developmentSachiko Tsukamoto, Hideyoshi YokosawaBiochemical and Biophysical Research Communications|August 23, 2005
ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activityTomoharu Takeuchi, Hideyoshi YokosawaGan to Kagaku Ryoho. Cancer & Chemotherapy|January 16, 2008
[A new mechanism of ubiquitin-dependent proteolytic pathway--polyubiquitin chain recognition and proteasomal targeting]Hiroyuki Kawahara, Hideyoshi YokosawaMethods in Enzymology|December 13, 2005
Production of antipolyubiquitin monoclonal antibodies and their use for characterization and isolation of polyubiquitinated proteinsMasahiro Fujimuro, Hideyoshi YokosawaExpert Opinion on Therapeutic Targets|April 29, 2009
Targeting the proteasome pathwaySachiko Tsukamoto, Hideyoshi YokosawaDevelopment, Growth & Differentiation|June 7, 2023
Evidence for the involvement of the Rho GTP-binding protein in egg activation of the ascidian Halocynthia roretziSatoshi Toratani, Hideyoshi YokosawaPageof 9